Mikael Sundahl, MSc, PhD
Dr Mikael Sundahl holds a PhD in Organic Chemistry, 1990, Chalmers University of Technology and is a Docent “Associate Professor” in Organic Chemistry, 1995, Chalmers University of Technology. He has a Master of Science and Technology in Chemical Engineering, 1985, Chalmers University of Technology. Mikael Sundahl has been Principal Scientist, Novo Nordisk (Inhaled Insulin) 2006-2008, and he has been Manager Analytical Development, AstraZeneca Lund, (Inhaled products for Asthma and COPD) 2001-2006. During 1996–2001, he was Manager – Organic Analytical Chemistry, Swedish National Testing and Research Institute (Indoor Air Quality, Environmental and Workplace Environment, Materials analysis). During 1990–1996, he was a Researcher at Chalmers University of Technology, including post doc at Tsukuba University. Since 2008, Mikael Sundahl has been Director Analytical Development, McNeil AB Helsingborg (Nicorette, Digestive health and Cough&Cold products).